Chitosan-Coated PLGA Nanoparticles Encapsulating Triamcinolone Acetonide as a Potential Candidate for Sustained Ocular Drug Delivery

The current treatment for the acquired retinal vasculopathies involves lifelong repeated intravitreal injections of either anti-vascular endothelial growth factor (VEGF) therapy or modulation of inflammation with steroids. Consequently, any treatment modification that decreases this treatment burden...

Descripción completa

Detalles Bibliográficos

Autores principales:	Madhuri Dandamudi, Peter McLoughlin, Gautam Behl, Sweta Rani, Lee Coffey, Anuj Chauhan, David Kent, Laurence Fitzhenry
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	MDPI AG 2021-09-01
Colección:	Pharmaceutics
Materias:	nanoparticles posterior segment eye diseases PLGA chitosan chitosan-coated nanoparticles triamcinolone acetonide
Acceso en línea:	https://www.mdpi.com/1999-4923/13/10/1590
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!